NeuroMetrix Launches Indiegogo Campaign for Quell™ Wearable Pain Relief Technology

WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced a pre-order campaign on the world's largest crowdfunding platform, Indiegogo. With the campaign that begins March 2, consumers and healthcare professionals will have the ability to purchase Quell Wearable Pain Relief Technology before it is available to the general public.

The NeuroMetrix campaign can be found at: Quell Indiegogo Campaign.

Frank McGillin, SVP and General Manager of Consumer Health at NeuroMetrix explained the campaign objective, "We are new to the consumer wearable category and wanted to seek feedback from the Indiegogo community to help finalize the design and deliver 100% drug free pain relief to millions of people who suffer from chronic pain."

Quell is FDA cleared for treatment of chronic pain without a prescription. It uses NeuroMetrix's proprietary non-invasive neurostimulation technology to provide relief from chronic pain, such as due to diabetes, sciatica, fibromyalgia, and osteoarthritis. The advanced wearable device is lightweight and can be worn during the day while active, and at night while sleeping. Users of the device will also have the option of using their smartphone to automatically track and personalize their pain therapy.

Consumers and medical professionals can visit QuellRelief.com to learn more, sign up to receive information, and support the Indiegogo campaign. The company expects to start shipping product in Spring 2015. Quell will initially be available exclusively through doctor's office and online.

About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. For more information, please visit http://www.NeuroMetrix.com.

NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com

Source: NeuroMetrix, Inc.

News Provided by Acquire Media